BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26703863)

  • 1. The Uncertain Benefits of Combination Therapy for Clostridium difficile Infection.
    Young BE; Ochi H; Marimuthu K
    Clin Infect Dis; 2016 Mar; 62(6):809-10. PubMed ID: 26703863
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial Commentary: Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One?
    Wilcox MH
    Clin Infect Dis; 2015 Sep; 61(6):942-4. PubMed ID: 26024908
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Young, Ochi, and Marimuthu.
    Williamson JC; Gibbs HG; Ohl CA; Johnson JW; Beardsley JR; Luther VP; Rokas KE
    Clin Infect Dis; 2016 Mar; 62(6):810-1. PubMed ID: 26703864
    [No Abstract]   [Full Text] [Related]  

  • 4. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
    Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infections with Clostridium difficile following antibiotic therapy].
    Scheppach W
    MMW Fortschr Med; 2009 Oct; 151(40):47-9. PubMed ID: 19927920
    [No Abstract]   [Full Text] [Related]  

  • 6. Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
    Bakken JS
    Minn Med; 2009 Jul; 92(7):38-40. PubMed ID: 19708314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin plus metronidazole for Clostridium difficile infection.
    Drekonja DM
    Infect Control Hosp Epidemiol; 2010 Nov; 31(11):1205; author reply 1205-6. PubMed ID: 20929305
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
    Saffouri G; Khanna S; Estes L; Pardi D
    Am J Gastroenterol; 2014 Jun; 109(6):924-5. PubMed ID: 24896763
    [No Abstract]   [Full Text] [Related]  

  • 9. Rectal use of vancomycin.
    Bublin JG; Barton TL
    Ann Pharmacother; 1994 Dec; 28(12):1357-8. PubMed ID: 7696727
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium difficile pancolitis in adults with cystic fibrosis.
    Barker HC; Haworth CS; Williams D; Roberts P; Bilton D
    J Cyst Fibros; 2008 Sep; 7(5):444-7. PubMed ID: 18585983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first Clostridium difficile ribotype 027 strain isolated in Taiwan.
    Lai MJ; Chiueh TS; Huang ZY; Lin JC
    J Formos Med Assoc; 2016 Mar; 115(3):210-2. PubMed ID: 25791539
    [No Abstract]   [Full Text] [Related]  

  • 12. Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
    Pekova L; Shomov G; Mladenova I; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):383-6. PubMed ID: 18043555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing metronidazole resistant C. difficile.
    Gardner E; Meghani N; Mancuso P; Thomson A
    Nurse Pract; 2011 Nov; 36(11):8-11. PubMed ID: 22008593
    [No Abstract]   [Full Text] [Related]  

  • 14. Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
    Sethi AK; Al-Nassir WN; Nerandzic MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2009 Jan; 30(1):13-7. PubMed ID: 19046063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting the challenge of recurrent Clostridium difficile infection.
    Johnson S
    J Hosp Med; 2012 Mar; 7 Suppl 3():S11-3. PubMed ID: 22407994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
    Berman AL
    J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
    [No Abstract]   [Full Text] [Related]  

  • 17. Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitis.
    Godfrey MS; Finn A; Zainah H; Dapaah-Afriyie K
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25596288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole.
    Lewis BB; Buffie CG; Carter RA; Leiner I; Toussaint NC; Miller LC; Gobourne A; Ling L; Pamer EG
    J Infect Dis; 2015 Nov; 212(10):1656-65. PubMed ID: 25920320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Clostridium difficile infection in a French university hospital.
    Khanafer N; Blais L; Barbut F; Hirschel B; Vanhems P
    Scand J Gastroenterol; 2015; 50(10):1253-60. PubMed ID: 25877477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.